SEBETRALSTAT

SEBETRALSTAT was reported 539 times

SEBETRALSTAT is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 UNADJUSTED DOSE ADMINISTERED 6 0.0882
1 HEREDITARY ANGIOEDEMA 218 0.0203
2 PHLEBOSCLEROSIS 1 0.0128
3 PARAINFLUENZA VIRUS INFECTION 1 0.0097
4 BREATH SOUNDS ABSENT 1 0.0091
5 PARATRACHEAL LYMPHADENOPATHY 1 0.0082
6 INFECTIVE GLOSSITIS 1 0.0064
7 FEMALE REPRODUCTIVE TRACT DISORDER 1 0.0046
8 TETHERED CORD SYNDROME 1 0.0045
9 PILONIDAL DISEASE 1 0.0042
10 VAGUS NERVE DISORDER 1 0.0040
11 VASCULAR ACCESS SITE COMPLICATION 1 0.0040
12 MALABSORPTION FROM INJECTION SITE 1 0.0032
13 LUNG PERFORATION 1 0.0030
14 OESOPHAGEAL MOTILITY DISORDER 1 0.0028
15 VAGINAL PROLAPSE 1 0.0023
16 LACK OF SPONTANEOUS SPEECH 1 0.0023
17 CRANIAL NERVE PARALYSIS 1 0.0021
18 BRAIN NEOPLASM BENIGN 1 0.0020
19 AUTOSCOPY 1 0.0019
20 EJACULATION DELAYED 1 0.0018
21 THERAPEUTIC PRODUCT EFFECT DELAYED 8 0.0018
22 BLOOD OESTROGEN INCREASED 1 0.0017
23 UNINTENTIONAL USE FOR UNAPPROVED INDICATION 1 0.0017
24 PRECANCEROUS CONDITION 1 0.0015
25 HEAT EXHAUSTION 1 0.0012
26 INCORRECT DOSAGE ADMINISTERED 6 0.0012
27 MYCOTIC ALLERGY 1 0.0012
28 SPINAL CORD NEOPLASM 1 0.0011
29 SELECTIVE EATING DISORDER 1 0.0011
30 ANIMAL SCRATCH 1 0.0010
31 SLEEP DEFICIT 2 0.0009
32 FACIAL SPASM 1 0.0009
33 DENTAL OPERATION 2 0.0008
34 ALLERGY TO CHEMICALS 1 0.0008
35 INSURANCE ISSUE 12 0.0008
36 ENDOCRINE DISORDER 1 0.0008
37 DRUG EFFECT LESS THAN EXPECTED 11 0.0007
38 MIGRAINE WITH AURA 2 0.0007
39 INJECTION SITE SCAR 2 0.0007
40 FAT TISSUE INCREASED 1 0.0007
41 SKIN STRIAE 1 0.0007
42 TONGUE COATED 1 0.0006
43 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
44 GASTRIC INFECTION 2 0.0005
45 ALLERGIC REACTION TO EXCIPIENT 1 0.0005
46 EJACULATION FAILURE 1 0.0005
47 CHANGE OF BOWEL HABIT 1 0.0005
48 HORDEOLUM 2 0.0005
49 MIDDLE EAR EFFUSION 1 0.0005
50 SPINAL COLUMN INJURY 1 0.0004
51 TONGUE BLISTERING 1 0.0004
52 INFECTIOUS MONONUCLEOSIS 1 0.0004
53 PRODUCT DISTRIBUTION ISSUE 4 0.0004
54 BREATH ODOUR 1 0.0004
55 BRONCHITIS CHRONIC 1 0.0004
56 DERMAL CYST 1 0.0004
57 VASODILATATION 1 0.0004
58 MENOPAUSE 1 0.0004
59 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
60 LARYNGOSPASM 1 0.0004
61 ABDOMINAL RIGIDITY 1 0.0004
62 ORAL FUNGAL INFECTION 1 0.0004
63 STREPTOCOCCAL INFECTION 2 0.0004
64 THERAPEUTIC RESPONSE DELAYED 1 0.0004
65 NEUROLOGICAL SYMPTOM 2 0.0003
66 VOMITING PROJECTILE 1 0.0003
67 HYPERCAPNIA 1 0.0003
68 CENTRAL VENOUS CATHETERISATION 1 0.0003
69 EMERGENCY CARE 1 0.0003
70 BREAST CANCER RECURRENT 1 0.0003
71 PHARYNGEAL SWELLING 3 0.0003
72 LYME DISEASE 1 0.0003
73 POTENTIATING DRUG INTERACTION 1 0.0003
74 LUNG CARCINOMA CELL TYPE UNSPECIFIED STAGE IV 1 0.0003
75 NEOPLASM RECURRENCE 1 0.0003
76 FOOT FRACTURE 5 0.0003
77 CONJUNCTIVAL HAEMORRHAGE 1 0.0003
78 ORAL INFECTION 1 0.0003
79 PRODUCT DOSE OMISSION IN ERROR 7 0.0002
80 SPINAL FUSION SURGERY 1 0.0002
81 SHOULDER OPERATION 1 0.0002
82 ANURIA 2 0.0002
83 URINE OUTPUT DECREASED 2 0.0002
84 GINGIVAL SWELLING 1 0.0002
85 ROSACEA 1 0.0002
86 FLANK PAIN 2 0.0002
87 SKIN ABRASION 1 0.0002
88 ENDOMETRIOSIS 1 0.0002
89 HERNIA 4 0.0002
90 INCORRECT DOSE ADMINISTERED 47 0.0002
91 HORMONE LEVEL ABNORMAL 1 0.0002
92 PANCREATIC DISORDER 1 0.0002
93 LIGAMENT SPRAIN 2 0.0002
94 ANEURYSM 1 0.0002
95 VEIN DISORDER 1 0.0002
96 TOOTH ABSCESS 2 0.0002
97 PHLEBITIS 1 0.0002
98 TONSILLITIS 1 0.0002
99 BRAIN FOG 3 0.0002
100 FOOD POISONING 1 0.0002
101 CHEILITIS 1 0.0002
102 PHARYNGITIS STREPTOCOCCAL 2 0.0002
103 HIP SURGERY 1 0.0002
104 PRODUCT PRESCRIBING ISSUE 4 0.0002
105 VIRAL INFECTION 6 0.0002
106 ODYNOPHAGIA 1 0.0002
107 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
108 PRODUCT PREPARATION ISSUE 1 0.0002
109 ADVERSE REACTION 2 0.0002
110 EAR INFECTION 4 0.0002
111 CARDIAC FAILURE ACUTE 1 0.0001
112 LIMB INJURY 4 0.0001
113 ECCHYMOSIS 1 0.0001
114 HAND FRACTURE 1 0.0001
115 PRODUCT SUPPLY ISSUE 1 0.0001
116 THERAPY INTERRUPTED 10 0.0001
117 PARALYSIS 2 0.0001
118 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
119 INTENTIONAL UNDERDOSE 1 0.0001
120 BLINDNESS TRANSIENT 1 0.0001
121 PULMONARY MASS 2 0.0001
122 MUSCULOSKELETAL CHEST PAIN 2 0.0001
123 APHTHOUS ULCER 1 0.0001
124 SWELLING 12 0.0001
125 THERAPY PARTIAL RESPONDER 2 0.0001
126 GASTROINTESTINAL INFLAMMATION 1 0.0001
127 FURUNCLE 1 0.0001
128 MENSTRUAL DISORDER 1 0.0001
129 CARDIAC OPERATION 1 0.0001
130 MYOPATHY 1 0.0001
131 CARDIAC MURMUR 1 0.0001
132 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1 0.0001
133 THROAT TIGHTNESS 3 0.0001
134 LIP DRY 1 0.0001
135 INCREASED TENDENCY TO BRUISE 1 0.0001
136 APPENDICITIS 1 0.0001
137 LEUKAEMIA 1 0.0001
138 PRODUCT PACKAGING ISSUE 1 0.0001
139 AUTOIMMUNE DISORDER 1 0.0001
140 KIDNEY INFECTION 2 0.0001
141 THERAPY CHANGE 1 0.0001
142 PRESCRIBED UNDERDOSE 2 0.0001
143 SALIVARY HYPERSECRETION 1 0.0001
144 SPINAL FRACTURE 2 0.0001
145 PRODUCT ADMINISTRATION ERROR 2 0.0001
146 INFLUENZA 11 0.0001
147 WEIGHT INCREASED 22 0.0001
148 RIB FRACTURE 2 0.0001
149 POOR VENOUS ACCESS 1 0.0001
150 DENTAL CARIES 1 0.0001
151 LIP SWELLING 3 0.0001
152 TOOTH DISORDER 2 0.0001
153 OBSTRUCTIVE AIRWAYS DISORDER 1 0.0001
154 THERAPY NON-RESPONDER 4 0.0001
155 CHROMATURIA 2 0.0001
156 IMPAIRED DRIVING ABILITY 1 0.0001
157 NEPHROLITHIASIS 4 0.0001
158 METASTASES TO LUNG 1 0.0001
159 DYSPHAGIA 8 0.0001
160 LOCALISED INFECTION 2 0.0001
161 GENERALISED OEDEMA 1 0.0001
162 PHARYNGITIS 1 0.0001
163 TOOTH EXTRACTION 1 0.0001
164 ILLNESS 8 0.0001
165 INFUSION SITE PAIN 1 0.0001
166 DRUG INEFFECTIVE 102 0.0001
167 ORAL CANDIDIASIS 1 0.0001
168 TOOTH INFECTION 1 0.0001
169 DYSMENORRHOEA 1 0.0001
170 PRODUCT DOSE OMISSION ISSUE 22 0.0001
171 MALIGNANT MELANOMA 1 0.0001
172 CENTRAL NERVOUS SYSTEM LESION 1 0.0001
173 ANAPHYLACTIC REACTION 4 0.0001
174 HUNGER 1 0.0001
175 SEASONAL ALLERGY 1 0.0001
176 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 5 0.0001
177 INTENTIONAL DOSE OMISSION 2 0.0001
178 HYPERSOMNIA 2 0.0001
179 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
180 DYSPHONIA 4 0.0001
181 SINUSITIS 7 0.0001
182 WEIGHT DECREASED 19 0.0001
183 RESPIRATORY DISORDER 2 0.0001
184 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 12 0.0001
185 FEELING HOT 4 0.0001
186 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
187 RENAL DISORDER 3 0.0001
188 SWOLLEN TONGUE 2 0.0001
189 ABSCESS 1 0.0001
190 GAIT INABILITY 2 0.0001
191 PRODUCT USE ISSUE 11 0.0001
192 ABDOMINAL DISTENSION 6 0.0001
193 HEADACHE 36 0.0001
194 NERVOUSNESS 3 0.0001
195 COLD SWEAT 1 0.0001
196 HEAD DISCOMFORT 1 0.0001
197 GALLBLADDER DISORDER 1 0.0001
198 GASTROINTESTINAL DISORDER 5 0.0001
199 ADVERSE DRUG REACTION 5 0.0001
200 GASTROENTERITIS VIRAL 1 0.0001
201 PELVIC PAIN 1 0.0001
202 NASOPHARYNGITIS 10 0.0001
203 HYPERSENSITIVITY 10 0.0001
204 URTICARIA 9 0.0001
205 FRACTURE 1 0.0001
206 COLITIS 2 0.0001
207 SLEEP APNOEA SYNDROME 1 0.0001
208 POST PROCEDURAL COMPLICATION 1 0.0001
209 LOWER LIMB FRACTURE 1 0.0001
210 ERUCTATION 1 0.0001
211 EAR PAIN 1 0.0001
212 CHOKING 1 0.0001
213 PREGNANCY 1 0.0000
214 FEEDING DISORDER 1 0.0000
215 MOUTH ULCERATION 1 0.0000
216 RETCHING 1 0.0000
217 JOINT INJURY 1 0.0000
218 IMPAIRED WORK ABILITY 1 0.0000
219 IRRITABLE BOWEL SYNDROME 1 0.0000
220 LIVER FUNCTION TEST INCREASED 1 0.0000
221 SWELLING FACE 3 0.0000
222 MENTAL DISORDER 2 0.0000
223 RASH MACULO-PAPULAR 1 0.0000
224 PULMONARY OEDEMA 2 0.0000
225 PRODUCT AVAILABILITY ISSUE 1 0.0000
226 OROPHARYNGEAL PAIN 4 0.0000
227 MIGRAINE 4 0.0000
228 PRESYNCOPE 1 0.0000
229 NEURALGIA 1 0.0000
230 EPISTAXIS 3 0.0000
231 HYPOPHAGIA 1 0.0000
232 FALL 13 0.0000
233 ERECTILE DYSFUNCTION 1 0.0000
234 VOMITING 18 0.0000
235 DEAFNESS 1 0.0000
236 SPEECH DISORDER 2 0.0000
237 GASTRITIS 1 0.0000
238 DEPRESSED MOOD 2 0.0000
239 DRUG INTERACTION 6 0.0000
240 DEHYDRATION 5 0.0000
241 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
242 DRY MOUTH 3 0.0000
243 RASH PRURITIC 2 0.0000
244 TREATMENT NONCOMPLIANCE 2 0.0000
245 DIVERTICULITIS 1 0.0000
246 FEELING COLD 1 0.0000
247 PAIN IN JAW 1 0.0000
248 INFECTION 5 0.0000
249 ABDOMINAL PAIN 8 0.0000
250 NEEDLE ISSUE 1 0.0000
251 PRURITUS 13 0.0000
252 ADVERSE EVENT 3 0.0000
253 HOSPITALISATION 5 0.0000
254 PERIPHERAL SWELLING 5 0.0000
255 EXPOSURE DURING PREGNANCY 2 0.0000
256 NERVOUS SYSTEM DISORDER 1 0.0000
257 CYSTITIS 1 0.0000
258 CONTUSION 3 0.0000
259 HYPERHIDROSIS 4 0.0000
260 DEEP VEIN THROMBOSIS 2 0.0000
261 INFUSION RELATED REACTION 2 0.0000
262 SYNCOPE 3 0.0000
263 URINARY RETENTION 1 0.0000
264 ABDOMINAL DISCOMFORT 5 0.0000
265 TYPE 2 DIABETES MELLITUS 1 0.0000
266 MALAISE 13 0.0000
267 HEPATIC ENZYME INCREASED 2 0.0000
268 FEELING ABNORMAL 7 0.0000
269 BURNING SENSATION 2 0.0000
270 SKIN BURNING SENSATION 2 0.0000
271 DYSURIA 1 0.0000
272 EYE SWELLING 1 0.0000
273 MUSCULAR WEAKNESS 3 0.0000
274 INJECTION SITE SWELLING 2 0.0000
275 DIZZINESS 13 0.0000
276 PALPITATIONS 3 0.0000
277 ARTHRITIS 2 0.0000
278 INJECTION SITE BRUISING 2 0.0000
279 HYPOTENSION 5 0.0000
280 EXTRA DOSE ADMINISTERED 1 0.0000
281 PSORIATIC ARTHROPATHY 1 0.0000
282 OSTEOPOROSIS 1 0.0000
283 TREMOR 4 0.0000
284 RENAL IMPAIRMENT 2 0.0000
285 URINARY TRACT INFECTION 4 0.0000
286 OVERDOSE 5 0.0000
287 SEPTIC SHOCK 1 0.0000
288 RASH 10 0.0000
289 INTENTIONAL PRODUCT MISUSE 2 0.0000
290 INTENTIONAL PRODUCT USE ISSUE 2 0.0000
291 MUSCULOSKELETAL STIFFNESS 2 0.0000
292 ANGIOEDEMA 1 0.0000
293 LIVER DISORDER 1 0.0000
294 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
295 PNEUMONIA 7 0.0000
296 COGNITIVE DISORDER 1 0.0000
297 RENAL CANCER 1 0.0000
298 PRODUCTIVE COUGH 1 0.0000
299 RASH ERYTHEMATOUS 1 0.0000
300 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1 0.0000
301 DRUG INTOLERANCE 2 0.0000
302 DRY EYE 1 0.0000
303 ABDOMINAL PAIN UPPER 4 0.0000
304 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
305 PARAESTHESIA 3 0.0000
306 NAUSEA 15 0.0000
307 PANCREATITIS 1 0.0000
308 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
309 OEDEMA 1 0.0000
310 SEPSIS 2 0.0000
311 PAIN 11 0.0000
312 BLISTER 1 0.0000
313 HERPES ZOSTER 1 0.0000
314 SEIZURE 2 0.0000
315 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
316 BACK PAIN 4 0.0000
317 COVID-19 3 0.0000
318 BONE PAIN 1 0.0000
319 CHILLS 2 0.0000
320 DISEASE PROGRESSION 2 0.0000
321 STOMATITIS 1 0.0000
322 ILL-DEFINED DISORDER 1 0.0000
323 INJECTION SITE PAIN 5 0.0000
324 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
325 CHEST PAIN 3 0.0000
326 INJECTION SITE ERYTHEMA 2 0.0000
327 OFF LABEL USE 14 0.0000
328 RHINORRHOEA 1 0.0000
329 BLOOD PRESSURE DECREASED 1 0.0000
330 INSOMNIA 4 0.0000
331 NEOPLASM MALIGNANT 1 0.0000
332 INJECTION SITE PRURITUS 1 0.0000
333 VISION BLURRED 2 0.0000
334 MEMORY IMPAIRMENT 2 0.0000
335 INJECTION SITE REACTION 1 0.0000
336 COUGH 4 0.0000
337 SLEEP DISORDER 1 0.0000
338 FATIGUE 11 0.0000
339 MOBILITY DECREASED 1 0.0000
340 BRONCHITIS 1 0.0000
341 HYPOAESTHESIA 2 0.0000
342 UNEVALUABLE EVENT 1 0.0000
343 CHRONIC KIDNEY DISEASE 1 0.0000
344 CONDITION AGGRAVATED 4 0.0000
345 BLOOD PRESSURE INCREASED 2 0.0000
346 CARDIAC FAILURE CONGESTIVE 1 0.0000
347 DIARRHOEA 8 0.0000
348 INFLUENZA LIKE ILLNESS 1 0.0000
349 MYALGIA 2 0.0000
350 PYREXIA 4 0.0000
351 MYOCARDIAL INFARCTION 2 0.0000
352 TACHYCARDIA 1 0.0000
353 DEVICE ISSUE 1 0.0000
354 NO ADVERSE EVENT 2 0.0000
355 BREAST CANCER 1 0.0000
356 CARDIAC DISORDER 1 0.0000
357 DYSPNOEA 6 0.0000
358 ANXIETY 3 0.0000
359 PULMONARY EMBOLISM 1 0.0000
360 NEUROPATHY PERIPHERAL 1 0.0000
361 DYSPEPSIA 1 0.0000
362 HEART RATE INCREASED 1 0.0000
363 SOMNOLENCE 2 0.0000
364 CHEST DISCOMFORT 1 0.0000
365 ERYTHEMA 2 0.0000
366 CONSTIPATION 2 0.0000
367 RHEUMATOID ARTHRITIS 1 0.0000
368 JOINT SWELLING 1 0.0000
369 EMOTIONAL DISTRESS 1 0.0000
370 ASTHENIA 3 0.0000
371 LOSS OF CONSCIOUSNESS 1 0.0000
372 ARTHRALGIA 3 0.0000
373 CEREBROVASCULAR ACCIDENT 1 0.0000
374 MUSCLE SPASMS 1 0.0000
375 BLOOD GLUCOSE INCREASED 1 0.0000
376 GAIT DISTURBANCE 1 0.0000
377 ALOPECIA 1 0.0000
378 HYPERTENSION 1 0.0000
379 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
380 PAIN IN EXTREMITY 1 0.0000
381 DEATH 2 0.0000